Fibrillin 1 is the main constituent of extracellular microfibrils. Microfib
rils can exist as inividual structures or associate with elastin to form el
astic fibres. Fibrillin 1 mutations are the cause of the pleiotropic manife
stations of the Marfan syndrome (MFS) which principally involve the musculo
skeletal, ocular and cardiovascular systems. MFS pathogenesis requires high
levels of mutant fibrillin 1 molecules with dominant-negative activity on
microfibrillar assembly and function. Gene-targeting experiments in the mou
se have shed new light on fibrillin 1 function, genotype-phenotype correlat
ions and aneurysm progression. These experiments have documented the involv
ement of fibrillin 1 in mantaining tissue homeostasis, suggested the existe
nce of a critical threshold of functional microfibrils for tissue biomechan
ics, and outlined novel contributors to the pathogenic sequence of vascular
wall collapse.